Phase II Trial of Cetuximab, Gemcitabine, and Oxaliplatin Followed by Chemoradiation With Cetuximab for Locally Advanced (T4) Pancreatic Adenocarcinoma: Correlation of Smad4(Dpc4) Immunostaining With Pattern of Disease Progression

PURPOSE: This phase II trial was designed to assess the efficacy and safety of cetuximab, gemcitabine, and oxaliplatin followed by cetuximab, capecitabine, and radiation therapy in locally advanced pancreatic cancer (LAPC). PATIENTS AND METHODS: Treatment-naive eligible patients (n = 69) received in...

詳細記述

保存先:
書誌詳細
主要な著者: Crane, Christopher H., Varadhachary, Gauri R., Yordy, John S., Staerkel, Gregg A., Javle, Milind M., Safran, Howard, Haque, Waqar, Hobbs, Bridgett D., Krishnan, Sunil, Fleming, Jason B., Das, Prajnan, Lee, Jeffrey E., Abbruzzese, James L., Wolff, Robert A.
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Clinical Oncology 2011
主題:
Original Reports
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3157965/
https://ncbi.nlm.nih.gov/pubmed/21709185
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.33.8038
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料